DashboardAll companies
Run this on your own research
Healthcare · Biotechnology

Quince Therapeutics, Inc.

QNCXNASDAQ$32.83−$1.85 (−5.33%)Market closed
Market Cap
—
P/E
−0.1x
P/B
−0.23x
ROE
3016.5%

Price Chart

Daily, 1 year

Company Overview

FY 2025

Quince Therapeutics, Inc.

Healthcare · Biotechnology

Quince Therapeutics Inc. is a biotechnology company focused on discovering and developing innovative therapies aimed at treating medical conditions with a significant unmet need. By leveraging advanced technologies, the company dedicates its resources towards creating novel therapeutics that address the underlying mechanisms of diseases. Quince Therapeutics operates within the pharmaceutical and biotechnology sector, impacting both the healthcare and life sciences industries. The company's research and development initiatives are crucial in the realm of rare diseases and complex medical disorders, where few effective treatments are currently available. Through strategic partnerships and collaborations, Quince Therapeutics endeavours to translate scientific breakthroughs into practical, patient-centric solutions. In the broader financial market, Quince Therapeutics plays an integral role in driving innovation and progress within the healthcare sector, contributing to advancements that can lead to better patient outcomes and quality of life improvements worldwide. As a biotechnology entity, Quince Therapeutics is integral in the ongoing efforts to bring cutting-edge therapies from concept to clinical reality.

CEO
Dr. Dirk Thye M.D.
Employees
36
Sector
Healthcare
Industry
Biotechnology

Company Statistics

Valuation

P/E
−0.1x
P/B
−0.23x
P/S
—
EV/EBITDA
−1.0x
P/FCF
−0.2x

Margins

Gross
—
EBITDA
—
Operating
—
Pre-Tax
—
Net
—

Returns

ROA
−80.7%
ROE
3016.5%
ROIC
−48.5%

Growth (CAGR)

Rev 3Yr
—
Rev 5Yr
—
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
$5.8M
Net Debt
$123.4M
Debt/Equity
−361.9%
Interest Cov
—

Profile

Revenue
$0
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Quince Therapeutics, Inc. (QNCX) Stock Forecast 2026 $32.83 — Price, Financials & Analyst Targets | AlphaLenz